Joannes-Boyau Olivier, Rapaport Stephane, Bazin Romain, Fleureau Catherine, Janvier Gerard
Department of Anesthesiology and Critical Care II, University of Bordeaux, Pessac, France.
ASAIO J. 2004 Jan-Feb;50(1):102-9. doi: 10.1097/01.mat.0000104846.27116.ea.
The purpose of this study was to evaluate the effect of high volume continuous venovenous hemofiltration (HVCVVH) on hemodynamic and outcome in patients with septic shock. The primary end point was mortality at 28 days. Study design was a prospective case series, and study setting was a 12 bed intensive care unit at a university hospital. A total of 24 consecutive patients with septic shock were included, with dysfunction of more than two organs. All patients were treated by HVCVVH with ultrafiltration rate between 40 ml x kg(-1) x hr(-1) and 60 ml x kg(-1) x hr(-1) for 96 hours. In all patients, the increase in hemodynamic parameters was statistically significant (p < 0.05), with a significant linear decrease in norepinephrine doses (p < 0.05). The predicted 28 day mortality by three different severity scores was more than 70%, and the mortality in the hemofiltration group was 46% (p < 0.075). In the present study of septic shock patients with organ dysfunction, the hemodynamic parameters increased regularly during treatment by HVCVVH. This study suggests a beneficial effect of HVCVVH on 28 day mortality (46% vs. 70%), and further studies with larger cohorts are required.
本研究的目的是评估高容量连续性静脉-静脉血液滤过(HVCVVH)对感染性休克患者血流动力学及预后的影响。主要终点是28天死亡率。研究设计为前瞻性病例系列,研究地点是一所大学医院的12张床位的重症监护病房。共纳入24例连续性感染性休克患者,均存在两个以上器官功能障碍。所有患者均接受HVCVVH治疗,超滤率为40 ml·kg⁻¹·hr⁻¹至60 ml·kg⁻¹·hr⁻¹,持续96小时。所有患者血流动力学参数的增加具有统计学意义(p < 0.05),去甲肾上腺素剂量显著线性下降(p < 0.05)。三种不同严重程度评分预测的28天死亡率超过70%,血液滤过组的死亡率为46%(p < 0.075)。在本项针对伴有器官功能障碍的感染性休克患者的研究中,HVCVVH治疗期间血流动力学参数呈规律性增加。本研究提示HVCVVH对28天死亡率有有益影响(46%对70%),需要进一步开展更大样本量队列的研究。